Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00400608 · ClinicalTrials.gov registry record · Phase 4
A Study In Pediatric Subjects With Asthma Using ADVAIR HFA, ADVAIR HFA With Spacer, And ADVAIR DISKUS
A Phase 4 study of Asthma, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 4
- Development phase
- 28
- Enrollment target
- 3
- Study locations
NCT00400608 is a Phase 4 study of Asthma that has completed, run by GlaxoSmithKline. The registered enrollment target is 28 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (98% lower). The trial reports 3 study locations across 2 states.
The verdict
NCT00400608, a Phase 4 study of Asthma, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 28 participants
- Enrollment target
- 3
- Study locations
Study Summary
Collect PK/PD data for this age group to compare ADVAIR DISKUS with ADVAIR HFA
Conditions Studied
Interventions
- DRUG ADVAIR HFA
- DRUG ADVAIR DISKUS
Study Locations (3)
California
- GSK Investigational Site - Huntington Beach
- GSK Investigational Site - Long Beach
Oregon
- GSK Investigational Site - Medford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2006-10 |
| Est. Completion | 2007-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00400608
The ClinicalTrials.gov registry entry for NCT00400608 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (98% lower). The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 2 interventions - of which ADVAIR HFA is the first listed.
NCT00400608 reports 3 study locations spanning 2 distinct geographic areas - top geographies include California, Oregon.
Frequently Asked Questions
What is clinical trial NCT00400608 about?
NCT00400608 is a clinical study titled "A Study In Pediatric Subjects With Asthma Using ADVAIR HFA, ADVAIR HFA With Spacer, And ADVAIR DISKUS". Collect PK/PD data for this age group to compare ADVAIR DISKUS with ADVAIR HFA
What is the current status of trial NCT00400608?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 28 participants. The study started on 2006-10. Estimated completion is 2007-02.
What conditions does trial NCT00400608 study?
This clinical trial studies the following conditions: Asthma.
What interventions are being tested in trial NCT00400608?
The interventions under investigation include: ADVAIR HFA (DRUG), ADVAIR DISKUS (DRUG).
Who is sponsoring clinical trial NCT00400608?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00400608 being conducted?
This trial has 3 study locations across California, Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Measuring the Effect of Dupilumab Treatment on Mucociliary Clearance (MCC) in Subjects With Moderate to Severe Asthma
RECRUITING · Phase 4
-
Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Adult Patients With Uncontrolled Moderate to Severe Asthma
RECRUITING · Phase 4
-
Viral Infection in Asthma (VIA) Study
RECRUITING · Phase 4
-
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
RECRUITING · Phase 4
-
The Effects of Positive Airway Pressure on the Mucolytic Effects of NAC (TEAM)
RECRUITING · Phase 4
-
Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/Long-acting Beta-agonist (ICS/LABA) in Comparison to ICS Dose Escalation to High Dose ICS/LABA in Adolescent and Adult Patients With Uncontrolled Asthma
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.